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Background: The burden of stroke worldwide is increasing rapidly. There is paucity of data on post-stroke depression 
(PSD) among stroke survivors in Uganda, despite the high prevalence of PSD reported elsewhere. 
Methods: In a cross-sectional study, we assessed adult participants with confirmed first stroke with a standardized question- 
naire. The Patient Health Questionnaire-9  was used to assess for depression among non-aphasic patients while the Aphasic 
Depression Rating Scale was administered to aphasic patients. Univariable and multivariable analyses performed to describe 
associations with PSD. 
Results: Forty three females (58.9%) and 30 males (41.1%) who had a stroke participated. Fifty eight (79.5%) had ischemic 
strokes and 12 participants (16.4%) were aphasic. The prevalence of PSD among the study participants was 31.5%. PSD was 
higher among patients assessed within 6 months after the onset of stroke. PSD was strongly associated with the total Barthel 
index of activities of daily living (BIADL) score; p=0.001. There was no significant association between demographic char- 
acteristics and PSD. 
Conclusion: There is a high prevalence of unrecognized post-stroke depression. Post-stroke depression was strongly asso- 
ciated with the patient’s inability to undertake activities of daily life. There is urgent need for integration of screening for and 
management of post-stroke depression among stroke survivors. 
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Stroke is a common neurological problem and one of 
the leading causes of death in developing countries of 
the world1. Stroke is also the leading causes of  func- 
tional impairments, with 20% of  survivors requiring 
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permanently disabled2. Stroke patients have been con- 
sistently noted to experience changes in their emotional 
status that range from simple emotional reactions such 
as low motivation, indifference, and frustration to more 
complicated depressive symptoms like loss of appetite, 
insomnia, and feelings of  worthlessness3. Depression is 
the most common mood problem after stroke and it 
can occur within days to several months post-stroke4. 
Major depression is estimated at 10 - 27% among these 
stroke survivors while 15 - 40% will experience  symp- 
toms of  depression within two months following a 
stroke4. Previous studies have reported prevalence rates 
that have ranged from 18% to 61%, depending upon 
patient selection and criteria used5-7. In Nigeria, Oladiji et 
al found a prevalence of 25.5% among post-stroke 
patients attending an out-patient setting in Nigeria us- 
ing the depression anxiety stress scale8. A study in Fin-




land using DSM III-R found a prevalence of 40.1% 
among adult subjects with ischemic stroke9. 
 
 
It is widely accepted that the early recognition and man- 
agement of  depression is an important aspect at any 
stage of stroke rehabilitation10. Important socio-demo- 
graphic factors such as age above 55 years, female sex 
and living environment after stroke have been report- 
ed to increase the risk of PSD. Neurobiological mech- 
anisms, with the highest risk for depression in cases 
with a left hemispherical infarction and theories that 
catecholamines  may be depleted have been suggested 
among these patients3,11,12. Diagnosis of  PSD is chal- 
lenging; therefore, it often remains unrecognized and or 
under treated. PSD is associated with cognitive impair- 
ment, increased mortality and risk of falls13. 
 
Depressed stroke patients may  die at a significantly 
younger age than those without depression. The risk of 
dying is 3.5 times greater among those depressed within a 
10 year period following the acute event14. Depression has 
been reported to be an independent risk factor for 
vascular disease and myocardial infarction; this may be 
the cause of death among this population15,16. 
 
This is the first study to document PSD in Uganda and 
was aimed at determining the burden of  depression 
and the factors associated with depression among post- 
stroke survivors in our setting. With the increasing bur- 
den of stroke and its related complications, this study 
provides baseline information on the prevalence of fac- 
tors associated with PSD and severity of depression in 
post-stroke patients in Uganda. It also provides a basis 
for the integration of psychiatric care into the chron- 
ic care clinics. The adoption of the simple depression 
screening tool (PHQ-9) to guide health practitioners in 




Ethical consideration and informed consent 
The written informed consent was obtained from all 
study participants. The study, its potential risks and 
benefits to the patients were elaborated to the patients/ 
relatives in simple and concise language. Patient con- 
fidentiality was maintained at all times and no patient 
identifiers were collected.  Approval for conducting 
the study in the two hospitals was provided from the 
Department of Internal Medicine Mother Kevin Post- 
graduate Medical School and the School of Medicine, 
Research and Ethics Committee of Makerere Universi- 
ty College of Health Sciences (Ref no -2013-146) and 
Uganda National Council of Science and Technology. 
 
This was a cross sectional study conducted in two urban 
hospitals; St. Raphael of  St Francis Hospital Nsamb- 
ya and Mulago National Referral Hospital in Kampala, 
Uganda. These two hospitals provide specialist servic- 
es for neurology and are teaching hospitals for medical 
students. Nsambya hospital is a private not for profit, 
church aided institution, while Mulago is a government 
supported institution. Patients with confirmed stroke 
attending these two hospitals between February 2014 
to April 2014, who fulfilled the inclusion criteria and 
provided written, informed consented were enrolled 
for the study. The inclusion criteria included the fol- 
lowing; age 18 years and above, with a single episode of  
stroke confirmed by brain computed tomography (CT) 
scan; and written informed consent. We excluded 
patients who were medically unstable with concurrent 
systemic disease, patients who had a prior diagnosis of 
depression or other psychiatric disorder that could af- 
fect cognition prior to the onset of stroke. 
 
Using the stroke registry of St. Raphael of St Francis 
Hospital Nsambya post-stroke patients were contacted 
and appointments fixed on routine Medical clinic days 
of  Monday and Thursday; those patients who could 
not make it on the routine clinic days were scheduled 
on days of their convenience and met by a study team 
member. Patients attending the Neurology  clinic of 
Mulago Hospital Complex were enrolled at the weekly 
Wednesday neurology specialist outpatient clinic as they 
came for scheduled reviews. The information regard- 
ing the study was availed in Luganda a local language 
and English for those who did not understand Lugan- 
da. Patients or their eligible attendants who accepted to 
volunteer to participate signed written consent forms. 
Patients’ demographics and clinical characteristics were 
collected using a pre-tested questionnaire. A focused 
neurological examination was performed. Limb power 
was graded using the Medical Research Council (MRC) 
scale17. Patients’ admission and follow-up notes were re- 
viewed to complete and confirm clinical variables and 
CT scan findings. During this study, the PHQ-9 was 
used and it has been validated in a number of studies 
with a sensitivity of 80% and specificity of 78% using a 
cutoff of ≥1018,19. The study participants were then 
classified according to the PHQ-9 total severity score. 
The PHQ-9 classifies the severity total score as mini-




mal symptoms 5-9, minor depression, dysthymia, major 
depression, mild 10 -14, major depression, moderately 
severe 15 -19, and major depression, severe >2020,21. 
 
Among aphasic patients, the aphasic depression rating 
scale (ADRS) was used22. The clinicians ruled out phys- 
ical causes of  depression, normal bereavement and a 
history of manic or hypo manic episodes. Patients who 
scored less than 5 on the scale were considered to have 
no depression while those with scores between 5 and 
28 were considered depressed and further assessments 
performed20. For the aphasic patients, a score below 9 
was considered as no depression while a score above 9 
was considered as significant depression. For the apha- 
sic patients, a score below 9 was considered as no de- 
pression while a score above 9 was considered as signif- 
icant depression The main outcome was the patient’s 
score on either the PHQ-9 or the ADRS22. The Barthel 
index of activities of daily living (BIADL)  was used to 




Data management and analysis 
The data collected was double entered into EPI-DATA 
(version 2.1) software to minimize data entry errors. It 
was then exported to STATA software version 12 (Sta- 
ta Corporation, College Station, TX, USA) for analy- 
sis. Confidentiality was maintained by the use of serial 
numbers instead of patients’ names. Demographic and 
clinical characteristics  were described among the study 
participants using frequencies and proportions. The 
variables of age, duration and total BIADL score were 
compared using Wilcoxon rank sum test. We calculated 
odds ratios (OR) and corresponding 95 percent confi- 
dence intervals (95% CI) to express the odds of post 
stroke depression.. The extent and severity of PSD were 
described and categorized from the respective PHQ- 
9 or ADRS scores of the patients. The prevalence of 
PSD was calculated as a proportion of the total num- 
ber of post-stroke patients assessed for PSD. For these 
analyses, we defined depression as PHQ -9 score >5, 
and as ARDS- score >9. Patients’ performances on the 
PHQ-9 or ADRS were analyzed using Kruskal-Wallis 
test to determine association between the severity of 
PSD and duration since the onset of stroke symptoms. 
We used these results to inform the choice of factors to 
include in the multivariable analyses. Final choice of in- 
put variables to the model were: age, duration of stroke 
symptoms, BIADL score, weakness of right upper limb 
and lower limbs. Associations with p values less than 




Demographic characteristics of participants 
A total of  73 post-stroke participants were enrolled. 
Nearly sixty percent (43/73) of the study participants 
were females (Table 1). Forty eight percent (35/73) of 
the study participants were between the ages sixty and 
seventy nine. Majority of  the study participants, 75% 
were urban dwellers while the rest came from rural ar- 
eas. Only 22% (16/73) were unemployed. Nearly forty 
percent (29/73) of the study participants were enrolled 
and assessed within 3 months since the onset of stroke 
symptoms, while for 27% (20/73) their stroke symp- 
toms had lasted for more than 12 months prior to as- 
sessment.




Table 1: Demographic characteristics of the study subjects 
 
Characteristic                                                                                                    N (%) 
Sex 
Female                                                                                   43 (58.9) 
Age in years
20 – 39 
40 – 59 

















Urban residence                                                                                     55 (75.3) 
Employment type
Formal / salaried 
Informal/wage 
Unemployed 






More than one source 




Diploma/degree and higher 
Duration of symptoms since onset in months 
Up to 3 months 
3 – 6 months 
7 – 12 months 
More than 12 months 
Number of co-existent co-morbidities 
One 
Two 


























Stroke characteristics of participants 
Nearly seventy-nine percent (58/73) of the study par- 
ticipants had ischemic strokes while 21% (15/73) had 
hemorrhagic strokes. Nearly half of the study partici- 
pants (36/73) had stroke lesions involving the left hem- 
isphere while 33 involved the right. Only five percent 
(4/73) had lesions involving both  hemispheres. The 
temporal lobe was the commonest brain lobe involved 
among the study participants and majority (75%) of 
these had single lobar involvement. Seventy percent 
(51/73) had brain lesions that were bigger than 225 
mm2  while 30% (22/73) had lesions up to 225 mm2. 
Only 16% (12/73) were aphasic. 
Sixty seven percent  of  the  study participants had 
pre-existing hypertension, Diabetes was present in 7% 
(8/73), Human Immunodeficiency virus and Hyperten- 
sive heart disease each contributed 5% (6/73) while hy- 






















Figure 1: Co-existing medical conditions among the study participants. 
Majority of the study participants had co-existing hypertension  followed by diabetes mellitus. Six study participants had HIV infection and were receiving attendant care from 
HIV care clinics at Mulago and Nsambya hospitals. Other medical conditions included atrial fibrillation, rheumatoid arthritis, deep venous thrombosis, temporal arteritis, 
associated Parkinsonism, Alzheimer’s dementia, erectile dysfunction and benign prostatic hypertrophy.




Two of  the participants had associated atrial fibrilla- 
tion, rheumatoid arthritis while two had un-explained 
strokes with no identifiable risk factor. Other associ- 
ated diagnoses found in the study participants were 
deep venous thrombosis, temporal arteritis, metabolic 
syndrome, degenerative valvular heart disease, parkin- 
sonism, Alzheimer’s dementia, erectile dysfunction, and 
benign prostatic hypertrophy (Figure 1). 
 
Prevalence and severity of post-stroke depression 
The prevalence of  post-stroke depression was 31.5% 
(23/73); with a 95% CI: 20.6% - 42.4% among the 
study participants. 
 
Among the seventeen non-aphasic subjects with depres- 
sion, twelve (70.6%) had mild major depression, four 
(23.5%) had minimal symptoms of  depression while 
one (5.9%) had moderately severe depression. None 
was found to have severe depression. In the aphasic 
group with depression, six had significant depression 
using the aphasic depression rating scale. 
Only 37% (7/19) of both aphasic and non-aphasic par- 
ticipants were receiving treatment for their depressive 
illness despite regularly attending the neurology clinic. 
 
Association of post-stroke depression with demo- 
graphic characteristics 
None of the baseline demographic characteristics was 
significantly associated with  post-stroke  depression. 
Participants that had not attended formal education 



















Left hemisphere 36 (49.3) 
Both hemispheres 4 (5.5) 
Dominant hemisphere lesion 40 (54.8) 




Temporal lobe 36 (49.3) 
Parietal lobe 22 (30.1) 
Occipital lobe 2 (2.7) 




One 55 (75.3) 
Two 9 (12.3) 






Presence of aphasia 
 
12 (16.4) 
MRC grading of power in the limbs 
Right upper limb 




2 – 3 14 (19.2) 
4 – 5 51 (69.9) 
Right lower limb 
0 – 1 
 
8 ( 11.0) 
2 – 3 15(20.5) 
4 – 5 
Left upper limb 




2 – 3 12 (16.4) 
4 – 5 
Left lower limb 




2 – 3 8 (11.0) 
4 – 5 64 (87.7) 
Total score on BIADL <19 35 (47.9) 
Right handedness 69 (94.5) 




Association of post-stroke depression with stroke 
characteristics 
Post-stroke depression was commonly seen among par- 
ticipants who had the assessment done within 3 months 
after onset of  stroke, 13 (56.5%), compared to those 
beyond 3 months (p=0.047), OR 0.36, 95% CI 0.131- 
1.00). However multivariable analysis did not reveal any 
statistical significance (p=0.356, OR 0.54, 95% CI 0.15 
- 1.98). The location of strokes was not associated with 
PSD. Post stroke depression occurred proportionate- 
ly higher (35.3%) among patients with bigger lesions 
more than 225 mm2  compared to those with small- 
er lesions (22.7%), but was not statistically different, 
p=  0.732; OR 1.85, 95% 0.58 – 5.86). The presence 
of  aphasia was associated with a higher proportion 
of  PSD (50.0%) compared to those without aphasia 
(27.9%). There was a higher proportion of PSD among 
participants whose limb power was less than 4 on the 
MRC scale, with highest significance seen in those with 
right upper limb weakness, p=0.013. There was no as- 
sociation of  PSD with dominant hemisphere among 
the study participants, p=0.417; OR 0.66, 95%CI 0.25 
– 1.79). (Table 3)
 
 








Age in years, n (%)    
20-39 2(8.7) 4(54.8) 0.777 
40-59 8(34.8) 17(23.3)  
60-79 12(52.2) 23(31.5)  
80-99 1(4.3) 6(8.2)  
Gender, n (%)    
Male 6 (26.1) 24 (48.0) 0.207 
Female 17 (73.9) 26 (52.0)  
Marital status, n (%)    
Single 4 (17.4) 6 (12.0) 0.401 
Married 10 (43.5) 22 (44.0)  
Divorced 1 (4.4) 9 (18.0)  
Widowed 8 (34.8) 13 (26.0)  
Residence status, n (%)    
Rural 5 (21.7) 13 (26.0) 0.695 
Urban 18 (78.3) 37 (74.0)  
Employment status, n (%)    
Formal/salaried 7 (30.4) 17 (34.0) 0.485 
Informal/wage 9 (39.1) 24 (48.0)  
Unemployed 7 (30.04) 9 (18.0)  
Form of income n (%)    
Monthly salary 2 (22.2) 7 (77.8) 0.561 
Wage 1 (33.3) 2 (66.7)  
Pension 1 (100.0) 0 (0)  
Business revenue 7 (25.9) 20 (74.1)  
Dependant 9 (40.9) 13 (59.1)  
More than one source 3 (27.3) 8 (72.3)  
Education level, n (%)    
None 5 (21.7%) 3 (6.0%) 0.086 
Primary 5 (21.7%) 22 (44.0%)  
Secondary 2 (8.7%) 7 (14.0%)  
Higher 11 (47.8%) 18 (36.0%)  
 
 
The median (IQR) BIADL score for those who were de- 
pressed was significantly different from those who were 
not depressed; 14 (11 – 19) compared to 20 (15 -20) 
respectively with a p-value of 0.001 using Mann-Whit- 
ney U test.




Association  of  PSD  severity with  demographic 
characteristics 
The demographic characteristics studied included age, 
gender, marital status, residence, employment status, 
education level and forms of income. However there 
was no association of the demographic characteristics 
with PSD for both the PHQ-9 with p-values of 0.611, 
0.849, 0.965, 0.762, 0.285, 0.219 and 0.550 respectively. 
Even among the aphasic participants using the ADRS 
score, none of the demographic characteristics was also 
associated with PSD with p-values of 0.670, 1.00, 0.646, 
0.762, 0.285, 0.219, and 0.550 respectively.
 
Table 4: Association of post-stroke depression with stroke characteristics 
 
Characteristic  Depressed 
N=23 
Not  depressed 
N=50 
P 
Duration since onset in months, n (%) ≤3 14 (60.9) 15 (28.3) 0.128 
 3 -6 2 (8.7) 12 (22.6)  
 6-12 1 (4.3) 9 (17.0)  
 ≥12 6 (26.1) 14 (26.4)  
Number of co-morbidities, n (%) One 15 (65.2) 34 (68)  
 Two 2 (8.7) 11 (22) 0.316 
 3 and  more 6 (26.1) 5 (10)  
 




















 No 12 (52.2%) 21 (27.5%)  
Frontal lobe  involvement, n (%) Yes 7 (30.4) 12 (24.0) 0.561 
 No 16 (69.6) 38 (76.0)  
Temporal lobe  involvement, n (%) Yes 13 (56.6) 23(46.0) 0.404 
 No 10 (43.4) 27 (54.0)  
Parietal lobe  involvement, n (%) Yes 7 (30.4) 15 (30.0) 0.970 
 No 16 (69.6) 35 (70.0)  
Occipital lobe  involvement, n (%) Yes 0 (0.0) 2 (4.0) 1.000 
 No 23 (100) 48 (96.0)  
Posterior circulation, n (%) Yes 0 5 (6.8%) --- 
 No 0 68 (93.2%)  
Number of lobes involved, n (%) None 1 (4.3) 6 (12.0) 0.722 
 One 18 (78.3) 37 (74.0)  
 Two 3 (13.0) 6 (12.0)  
 ≥3 1 (4.3) 1 (2)  
Size  of lesion, n (%) ≤225 mm
2
 5 (21.7) 17 (34) 0.732 
 > 225  mm2 18 (78.3) 33 (66)  
Presence of aphasia, n (%) Yes 6 (26.1) 6 (12.0) 0.131 
 No 17 (73.9) 44 (88.0)  
RUL power, n (%) 0-1 2 (8.7) 6 (12.0) 0.013 
 2-3 9 (39.1) 5 (10.0)  
 4-5 12 (52.2) 39 (78.0)  
RLL power, n (%) 0-1 3 (13.0) 5 (10.0) 0.093 
 2-3 8 (34.8) 7 (14.0)  
 4-5 12 (52.2) 38 (76.0)  
Total score on BIADL Up to 19 18 (78.3) 17 (34.0) 0.001 
 20 5 (21.7) 33 (66.0)  
Handedness, n (%) Right 22 (95.6) 47 (94.0) 0.773 
 Left 1 (4.4) 3 (6.0)  
Key: RUL= right upper limb; RLL= right lower limb; LUL: left  upper limb; LLL:  left  lower limb;BIADL: 
Barthel index of activities of daily living. 
 
 
Relationship between severity of  post-stroke de- 
pression and the time period after stroke 
Among the non-aphasic patients with PSD, 10 partic- 
ipants out of  the 13 with moderate and moderately 
severe depression (76.9%) had a time period between 
onset of stroke symptoms and assessment of up to 6 
months; there was none in the 6 to 12 month group 
while 3 had a time period of  12 months and over 
(23.1%) (p= 0.128, OR 0.721, 95% CI 0.474-1.098). On 
multivariable analysis, duration of stroke symptoms up to 
6 months was associated with more severe PSD only if 
BIADL score was below full capacity (p= 0.091, OR 
1.199, 95% CI 0.290-4.963).




Table 5: Association of severity of PSD with stroke characteristics 
 
Characteristics                                                                              PHQ – 9 score                 ADRS                          PHQ-9                        ADRS 
Min              Mild               Mod –Sev     9-32                            P – value                   P – value 
(5 – 9)          (10 – 14)       (15 –19) 
Duration since onset in months 
≤ 3                                                                          1                   8                     0                     5                                 0.200                          0.030 
3-6                                                                         0                   2                     0                     0 
6-12                                                                       1                   0                     0                     0 
≥ 12                                                                        2                   2                     1                     1 
Number of co-morbidities 
1                                                                             1                   8                     1                     5                                 0.562                          0.286 
2                                                                             1                   1                     0                     0 
≥3                                                                           2                   3                     0                     1 
Type of stroke 
Hemorrhagic                                                        1                   3                     0                     1                                 0.849                          0.857 
Ischemic                                                                3                   9                     1                     5 
Anatomical site of lesion 
Right                                                                      2                   5                     1                     3                                 0.528                          1.000 
Left                                                                        2                   7                     0                     3 
Dominant side 
Yes                                                                          2                   6                     0                     3                                 ----                              0.350 
No                                                                          2                   6                     1                     3 
Lobar involvement 
Frontal                                                                   1                   3                     0                     0                                 0.801                          0.072 
Temporal                                                               2                   5                     1                     2 
Parietal                                                                  1                   3                     0                     3 
Number of lobes involved 
None                                                                      0                   1                     0                     0                                 0.279                          0.143 
1                                                                             4                   11                   1                     2 
2                                                                             0                   0                     0                     3 
≥ 3                                                                          0                   0                     0                     1 
Size of lesion 
≤ 22.5mm²                                                            1                   3                     1                     0                                 0.279                          0.143 
≥ 225mm²                                                             3                   9                     0                     6 
RUL power 
0 – 1                                                                       1                   0                     0                     1                                 0.124                          0.459 
2 – 3                                                                       0                   7                     0                     2 
4 – 5                                                                       3                   5                     1                     3 
RLL power 
0 – 1                                                                       0                   0                     0                     1                                 0.319                          0.233 
2 – 3                                                                       1                   7                     0                     1 
4 – 5                                                                       3                   5                     1                     3 
Total BIADL score 
≤ 19                                                                        1                   11                   0                     6                                 0.011                          ----- 
> 20                                                                        3                   1                     1                     0 
KEY: ADRS- Aphasic depression rating scale, BIADL- Barthel index of activities of daily living; RUL= right upper limb; RLL= right lower limb; 




This is the first study to describe the burden of post 
stroke depression in Uganda, although various studies 
have been conducted worldwide. The study was aimed 
at determining the burden of depression and the fac- 
tors associated with post stroke depression and provide 
baseline data for integration of psychiatric care in the 
neurology clinics in Uganda. 
We found a high prevalence (31.5%) of post-stroke de- 
pression and only seven of these subjects were receiving 
treatment for their depressive illnesses. This illustrates 
the treatment gap among stroke survivors and high-




lights the implications of their health outcomes. Earli- 
er studies have reported a prevalence of 25.5% among 
post-stroke patients attending an out-patient setting in 
Nigeria using the depression anxiety stress scale8, while 
using DSM III-R a prevalence of 40.1% was reported9. 
The variation in prevalence among the various studies 
may be partly explained by the use of various tools by 
individual studies, presence of other causes of depres- 
sion and possible differences in how samples were en- 
rolled. It might also be due to the complexity of stroke 
patients for whom ordinary tools for depression may 
not be appropriate24. 
 
Majority of the study participants were elderly females 
and mostly urban dwellers. This is similar to earlier 
work describing stroke in Uganda, which noted simi- 
lar percentages of females25. The greater proportion of 
women with PSD in this study could be attributed to 
the generally better health seeking practices when com- 
pared to males  due to gender differences in medical 
care utilization26. However, some studies have reported 
associations of  depression and stroke among middle 
aged women27-30. Also regarding the sex-based differ- 
ences, it could be attributed to response bias created 
by the greater tendency for women to remember and 
report symptoms of depression31. In our study, gender 
was not found to be an important risk factor of PSD, 
compared to other studies though the female gender 
contributed to 73.9% of study subjects with PSD. 
 
Post-stroke depression (PSD) runs a chronic course 
and this enormously determines the health outcomes, 
including disability, morbidity and mortality32,33. About 
one third of all stroke survivors at any time during their 
follow-up may show depressive symptoms7. PSD may 
persist for 3–6 months after stroke with highest inci- 
dence occurring within 3 months after onset of stroke 
4. Overall the prevalence of post stroke depression re- 
duces over time with an improvements in activities of 
daily living if treatment is initiated early3. In this present 
study, majority of  the study participants (76.9%) had 
developed moderate and moderately severe depression 
within six months of onset of stroke symptoms. This 
is much higher than the prevalence of PSD compared 
to other African countries8,34. This might be due to dif- 
ferent study settings and study methods, aphasic stroke 
subjects were excluded from these studies. Yet aphasia 
has been reported to be having a profound effect on 
a patient’s life leading to depression35. The exclusion of 
aphasic patients might have contributed to the low 
prevalence in these studies. In this study the duration 
of  stroke symptoms up to 6 months was associated 
with more severe PSD only if BIADL score was below 
full capacity. The social circumstances and personality 
issues may be important in prevalence of  depression 
among different communities and races. The time of 
duration of  stroke does not affect PSD occurrence. 
However, depressive symptoms are frequent and are 
likely to prevail at longer follow-up times. The duration of 
the depressive symptoms is associated with stroke 
severity and functional outcome from 2 months on- 
wards9. 
 
In this present study urban dwellers had higher propor- 
tions of PSD compared to rural dwellers; this is similar 
to earlier work36. This could be due to locations where 
the two centers where this study was conducted are ur- 
ban and serve mainly urban dwellers, although one of 
them is a national referral serving the whole country. In 
addition the demands of life could be more strenuous 
coupled with less community support which is  more 
likely to prevail among urban dwellers37. The uncertain- 
ties of  getting through a day that are associated with 
unemployment could explain the higher prevalence of 
PSD among the unemployed38. The higher proportion 
among the non-educated  is most probably coupled with 
the lack of skills to sustain themselves especially in the 
presence of such a debilitating condition as stroke39,40. 
 
Notably none of  the patients with occipital or brain- 
stem lesions had depression and this is similar to earlier 
findings41  which could be because posterior circulation 
areas of the brain are not involved in personality and 
executive functions. In this present study, the sample 
size was too small to permit an accurate assessment of 
PSD in relation to stroke location. 
 
In this present study, the size of lesions involving any 
of  the lobes of  the brain as well having lesions big- 
ger than the arbitrary lacunar level of 15 mm was as- 
sociated with a higher proportion of  PSD. A recent 
biological study has reported that cytokine changes are 
significantly higher among patients with bigger ischem- ic 
lesions, and such patients have been found to have 
higher levels of  PSD and more profound disability42 
and therefore the higher prevalence of PSD among the 
physically impeded subjects. This biological basis could 
explain why involvement of the dominant side was not 
associated with higher proportions of PSD in our par- 
ticipants. Depression was also found more commonly




among the aphasic patients. Speech is a vital part of 
human nature and communication and therefore its ab- 
sence is a big cause of distress and depression; this is 
similar to previous studies that have noted aphasia as a 
severely disabling condition that markedly contributes to 
the severity and persistence of PSD24. 
 
Disability has been recognized as a big impediment to 
performance of social roles1 and is the focus of current 
rehabilitation strategies among post-stroke patients. In 
this present study, there was a statistically significant re- 
lationship between PSD and reduced limb power espe- 
cially when the weakness involved the dominant hand. 
Among our participants, those with impaired perfor- 
mance of  activities of  daily living arising from limb 
weakness demonstrated very high proportions of PSD 
of up to 51.4%. Previous studies have demonstrated a 
significant relation between the severity or existence of 
PSD and severity of impairment in Activities of Daily 
Living (ADLs) and that depression influences recovery in 
ADLs3,43. This underlines the fact that there is need to 
do universal screening for PSD among all stroke sur- 
vivors but especially those with physical impairment. 
 
The integration of mental health care into chronic care 
clinics is currently being advocated for; however this 
still remains a challenge in resource limited settings like 
Uganda. Post stroke care in Uganda is provided for by 
neurology specialist clinics and in this present study, we 
found that only seven of the study subjects with PSD 
had been initiated on tri-cyclic anti-depressants  in the 
right doses. Instituting mental health liaison teams in 
primary care would be a long term solution to address 
these challenges and also help provide holistic care for 
post stroke sufferers. We would also recommend the 
utilization of simple screening tools available like PHQ 
– 9 by the care providers for such patients. Routine sen- 
sitization of the care providers as well as highlighting 
this high prevalence would help us institute measures 
to mitigate this. 
 
Stroke rehabilitation programs including self-manage- 
ment programs should be instituted into care for post- 
stroke patients so as to help mitigate disability arising 
from stroke.  Further studies are needed to assess the 
relationship between physical disability and the devel- 
opment of  post-stroke depression among our popu- 
lation. More studies are needed to determine if PSD 
improves with changes in activities of daily living. 
Limitations 
This study has several limitations because of the nature 
of  the study population: for example, the small sam- 
ple size, unequal gender distribution, and longer post- 
stroke duration. The major limitation was the preselect- 
ed nature of the study population; patients with mild 
or severe strokes are not likely to have been included. 
The methods of  assessing depression were screening 
measures which reflect depressive symptomatology and 
there may have been an over diagnosis of depression. 
The diagnosis of  PSD was made by a physician with 
help of a psychiatrist. 
 
Conclusion 
There is a high prevalence of post-stroke depression in 
stroke patients in two urban hospitals in Uganda. There is 
a need to integrate mental health liaison services and 
utilization of  already available screening tools in the 
neurology primary care clinics to improve our patient 
care. Institution of  anti-depressive therapy provides 
benefit not only for the mood but also for functional 
recovery. Data from this study will also contribute to 
development of evidence based local protocols for the 
assessment of depression in post-stroke patients. 
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BIADL – Barthel index of activities of daily living 
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